Evaluation of the efficacy and surgical-related safety of neoadjuvant immunochemotherapy in advanced resectable none small cell lung cancer (NSCLC)

BackgroundThe emergence of immune checkpoint inhibitors (ICIs) has brought about a paradigm shift in the treatment landscape of non-small cell lung cancer (NSCLC). Despite the promising long-term survival outcomes and optimization of pathological complete response (cPR) demonstrated by various studi...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Qin Wang, Chen Qi, Jing Luo, Nan Xu, Mao-tian Xu, Yong Qiang, Chi Zhang, Yi Shen
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2023-12-01
Serie:	Frontiers in Oncology
Soggetti:	non-small cell lung cancer neoadjuvant therapy neoadjuvant immunotherapy neoadjuvant immunochemotherapy surgical-related safety
Accesso online:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1239451/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!